Trial
NCT02721888
Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Centre Hospitalier Universitaire Dijon
Collaborators
—
Condition
Type 2 Diabetes
Intervention
Liraglutide
Why stopped
Failure of inclusion
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-06